Published in Trends Immunol on October 01, 2005
Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci (2009) 5.00
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci (2009) 2.64
Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther (2010) 2.27
Transcriptome analysis of embryonic and adult sensory axons reveals changes in mRNA repertoire localization. RNA (2010) 2.07
Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun (2006) 2.00
Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity (2009) 1.95
Systemic antiinflammatory corticosteroid reduces mechanical pain behavior, sympathetic sprouting, and elevation of proinflammatory cytokines in a rat model of neuropathic pain. Anesthesiology (2007) 1.85
CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer. Biochem J (2008) 1.73
Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain. J Neurosci (2009) 1.59
Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm (2013) 1.43
Chemokines and pain mechanisms. Brain Res Rev (2008) 1.43
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc Natl Acad Sci U S A (2009) 1.24
Painful pathways induced by TLR stimulation of dorsal root ganglion neurons. J Immunol (2011) 1.24
Crosstalk between spinal astrocytes and neurons in nerve injury-induced neuropathic pain. PLoS One (2009) 1.14
MicroRNA modulation in complex regional pain syndrome. J Transl Med (2011) 1.14
Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain (2013) 1.10
Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J (2011) 1.06
Urinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide (VIP)-/- mice. J Mol Neurosci (2008) 1.02
Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain. J Neuroinflammation (2012) 0.89
CXCR4 chemokine receptor signaling mediates pain in diabetic neuropathy. Mol Pain (2014) 0.87
Elevated blood levels of inflammatory monocytes (CD14+ CD16+ ) in patients with complex regional pain syndrome. Clin Exp Immunol (2011) 0.85
In search of analgesia: emerging roles of GPCRs in pain. Mol Interv (2009) 0.85
Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour. J Neurochem (2008) 0.84
Fibromyalgia Syndrome in Need of Effective Treatments. J Pharmacol Exp Ther (2015) 0.83
Plasma amino acids changes in complex regional pain syndrome. Pain Res Treat (2013) 0.82
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model. Biomed Res Int (2015) 0.80
PKC-NF-κB are involved in CCL2-induced Nav1.8 expression and channel function in dorsal root ganglion neurons. Biosci Rep (2014) 0.79
Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic Pain. Front Microbiol (2016) 0.78
Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid Receptor/Chemokine Receptor5 Heteromer (MOR-CCR5). J Med Chem (2015) 0.78
Psychologic and biologic factors associated with fatigue in patients with persistent radiculopathy. Pain Manag Nurs (2010) 0.77
Effects of methylmercury contained in a diet mimicking the Wayana Amerindians contamination through fish consumption: mercury accumulation, metallothionein induction, gene expression variations, and role of the chemokine CCL2. Int J Mol Sci (2012) 0.77
Treatment of Cancer Pain by Targeting Cytokines. Mediators Inflamm (2015) 0.76
Close encounters of the third kind: evidence for contact with TNF-alpha. Pain (2010) 0.75
A novel case of resolved postherpetic neuralgia with subsequent development of trigeminal neuralgia: a case report and review of the literature. Case Rep Med (2013) 0.75
Peripheral Neuropathic Facial/Trigeminal Pain and RANTES/CCL5 in Jawbone Cavitation. Evid Based Complement Alternat Med (2015) 0.75
Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development. Mol Pain (2016) 0.75
CCR1 plays a critical role in modulating pain through hematopoietic and non-hematopoietic cells. PLoS One (2014) 0.75
Chemokine-ligands/receptors: multiplayers in traumatic spinal cord injury. Mediators Inflamm (2015) 0.75
Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain. Cell Mol Life Sci (2017) 0.75